|
|
|
 |
|
|
| Editorial |
|
| A tale of two trials: selectively replicating herpesviruses for brain tumors FREE |
| D H Kirn |
| Abstract | Full text | PDF |
|
| 815 |
|
| Inherited disease |
|
Anti-inflammatory action of type I interferons deduced from mice expressing interferon  FREE |
| L Boscá, O G Bodelón, S Hortelano, A Casellas & F Bosch |
| Abstract | Full text | PDF |
|
| 817 |
|
| Nonviral transfer technology |
|
| Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo FREE |
| L Heller, M J Jaroszeski, D Coppola, C Pottinger, R Gilbert & R Heller |
| Abstract | Full text | PDF |
|
| 826 |
|
| Cell based therapy |
|
| Efficiency of transgenic T cell generation from gene-marked cultured human CD34+ cord blood cells is determined by their maturity and the cytokines present in the culture medium FREE |
| B Verhasselt, E Naessens, M De Smedt & J Plum |
| Abstract | Full text | PDF |
|
| 830 |
|
| Cell based therapy |
|
| Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity FREE |
| Y S Kim, C H Sonn, S-G Paik & A L M Bothwell |
| Abstract | Full text | PDF |
|
| 837 |
|
| Acquired diseases |
|
| Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model FREE |
| Y Horiguchi, W A Larchian, R Kaplinsky, W R Fair & W D W Heston |
| Abstract | Full text | PDF |
|
| 844 |
|
| Antisense ATM gene therapy: a strategy to increase the radiosensitivity of human tumors FREE |
| C Guha, U Guha, S Tribius, A Alfieri, D Casper, P Chakravarty, W Mellado, T K Pandita & B Vikram |
| Abstract | Full text | PDF |
|
| 852 |
|
| Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma FREE |
| R Rampling, G Cruickshank, V Papanastassiou, J Nicoll, D Hadley, D Brennan, R Petty, A MacLean, J Harland, E McKie, R Mabbs & M Brown |
| Abstract | Full text | PDF |
|
| 859 |
|
| Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial FREE |
| J M Markert, M D Medlock, S D Rabkin, G Y Gillespie, T Todo, W D Hunter, C A Palmer, F Feigenbaum, C Tornatore, F Tufaro & R L Martuza |
| Abstract | Full text | PDF |
|
| 867 |
|
| Viral transfer technology |
|
| Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system FREE |
| S Rubinchik, R Ding, A J Qiu, F Zhang & J Dong |
| Abstract | Full text | PDF |
|
| 875 |
|
| Viral transfer technology |
|
| Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors FREE |
| D S Strayer, R J Pomerantz, M Yu, M Rosenzweig, M BouHamdan, S Yurasov, R P Johnson & H Goldstein |
| Abstract | Full text | PDF |
|
| 886 |
|
| Viral transfer technology |
|
| Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers FREE |
| U Modlich, C W Pugh & R Bicknell |
| Abstract | Full text | PDF |
|
| 896 |
|
|
|
| May 2000, Volume 7, Number 10 |
|
| <Previous Issue Next > |
